RxDoctor Payments Data

Cameron Whitler, DO

Cardiovascular Disease · Evansville, INNPI 1265963797

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (52.2%), food and beverage and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Abbott at 37.7% of the total. Reporting peaked in 2023 at $10,530 and has fallen 95.5% since, to $472 in 2025.

$16,279in general payments, 2019–2025

Across 122 payments — averaging $133.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Medtronic$5K
  • Boston Scientific$842
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$702
  • Abiomed$672
  • Amgen$598
  • plus $2K from 20 others

What the payments were for

  • Grants$8,50052%
  • Food & beverage$7,35845%
  • Education$4062%
  • Entertainment$150%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,279 in reported general payments places this provider in the 85th percentile of 408 cardiovascular disease providers in Indiana.

See all cardiovascular disease providers in Indiana →

Medicare billing

Part B allowed, 2024
$55,209
Medicare patients
335
Services billed
703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor18$19,203
ClopidogrelClopidogrel Bisulfate144$1,321
Atorvastatin Calcium22$326
Metoprolol Succinate26$318
Rosuvastatin Calcium21$169
Isosorbide Mononitrate ErIsosorbide Mononitrate11$142
Nitroglycerin11$103
Losartan Potassium11$100
Furosemide18$43

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Evansville

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →